Anti-TNF therapy is the mainstay for the treatment of moderate-to-severe inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC) [3]. This evidence concerns the gene TNF and inflammatory bowel disease.